Abstract: Systems and methods for customer journey optimization are described.

Abstract: An instrument to prepare and safely place an intra-uterine device in uterus of a woman, comprising a dynamic stopper, a string management arrangement whereby a string of an IUD is in one of a locked condition or an unlocked condition, an operating device, further comprising a base, a cover a carriage, wherein the dynamic stopper slidably resides in the base and can slide by the sliding length, wherein the string exits from an outpoint and re-enters from an inpoint, the outpoint is at a trim length and the inpoint is at a conservative length. The string can be trimmed as per sounding measurement of uterus of woman, before inserting the instrument in uterus and string entanglement possibilities are eliminated, irrespective of type of IUD.

Abstract: A trial stimulation system includes a trial electrical stimulator. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: Present invention relates to development of prolyl hydroxylase inhibitor for treatment of Psoriasis and skin inflammatory diseases. Specifically, invention relates to development of compound of formula (Ia) for treatment of Psoriasis and skin inflammatory diseases. Invention also relates to pharmaceutical composition comprising compound of formula (Ia) for treatment of Psoriasis and skin inflammatory diseases.

Abstract: Present invention relates to development of compound of formula (Ia) for treatment of inflammatory bowel diseases. Invention also relates to pharmaceutical composition comprising therapeutically effective compound of formula (Ia) for treatment of inflammatory bowel diseases.

Abstract: A trial stimulation system includes a trial electrical stimulator. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: A trial stimulation system includes a trial electrical stimulator. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: The present invention relates to a vaccine capable to induce the formation of antibodies directed to angiopoietin-like 3 in vivo. More specifically, the present invention relates to a use of a vaccines which are able to influence the angiopoietin-like 3 mediated immune response for the treatment of liver diseases such as non-alcoholic steatohepatitis and non-alcoholic fatty liver disease and hyperlipidaemia, hypercholesterolemia, or atherosclerosis including the complications lead to the cardiovascular diseases (CVD) which causes morbidity and mortality.

Abstract: A trial stimulation system includes a trial electrical stimulator. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: A trial stimulation system includes a disposable trial electrical stimulator that, in some examples, is sterilized for a single use in a stimulation trial of one patient. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: Present invention provides the method of treating polycystic ovarian syndrome using compound of formula (I) or pharmaceutically acceptable salt thereof, preferably it provides method of treating polycystic ovarian syndrome in the patient diagnosed with NAFLD.

Abstract: The present invention relates to novel short chain peptides of formula (I) which can be useful as a vaccine when in conjugation with suitable immunogenic carrier and suitable adjuvant. These are useful for the treatment for the PCSK9 mediated diseases.

Abstract: The present invention relates to novel short chain peptides of formula (I) which can be useful as a vaccine when in conjugation with suitable immunogenic carrier and suitable adjuvant. These are useful for the treatment for the PCSK9 mediated diseases.

Abstract: A system for commissioning for first responders at a site of an incident is provided. The system includes a data processing device configured to: receive personnel data; generate a unique personnel profile based on the personnel data; communicating the unique personnel profile to a tag creation device for creation of a tag corresponding to the unique personnel profile; receive scanning location information of the tag, and cause display, at a monitoring display, of alert data associated with the scanning location information. The alert data is a result of applying at least one user-defined rule to the scanning locating information.

Abstract: A method for a wireless device (12) to facilitate personnel accountability is provided. Incident data is received. The incident data includes a location of an incident. A determination is made whether confirmation has been received that a user of the wireless device (12) agrees to respond to the incident. In response to determining confirmation has been received: a location of the wireless device (12) is determined, a first estimated time of arrival to the location of the incident from the location of the wireless device (12) is determined, transmission of the first estimated time of arrival is caused, a virtual region around the location of the incident is generated, a determination is made if the wireless device (12) enters the virtual region, transmission of a first update is caused in response to determining the wireless device (12) enters the virtual region.

Abstract: A trial stimulation system includes a disposable trial electrical stimulator that, in some examples, is sterilized for a single use in a stimulation trial of one patient. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: Techniques are disclosed relating to implementation and predictions for a queue map that specifies amounts of execution resources assigned to queues of applications managed by a resource negotiator module. In some embodiments, an apparatus is configured to generate a queue map. In some embodiments, the apparatus is configured to simulate predicted modifications to the queue map based on input of one or more applications to one or more queues. In some embodiments, the apparatus is configured to display the predicted modifications. In some embodiments, the apparatus is configured to modify a queue map based on the approval of the predicted modifications. In some embodiments, the disclosed prediction techniques may improve overall performance and efficiency of a multi-queue system and/or facilitate informed selection of queues for new applications.

Abstract: A trial stimulation system includes a disposable trial electrical stimulator that, in some examples, is sterilized for a single use in a stimulation trial of one patient. Additionally, systems for securing a disposable trial stimulator to the body of a patient are described, which may function to improve the durability of the system during the trial period and reduce the risk of damage or malfunction to the system due to lead/electrode dislocation and/or off-label uses like showering or bathing with the trial stimulator still secured to the body.

Abstract: A system for commissioning for first responders at a site of an incident is provided. The system includes a data processing device configured to: receive personnel data; generate a unique personnel profile based on the personnel data; communicating the unique personnel profile to a tag creation device for creation of a tag corresponding to the unique personnel profile; receive scanning location information of the tag, and cause display, at a monitoring display, of alert data associated with the scanning location information. The alert data is a result of applying at least one user-defined rule to the scanning locating information.

Abstract: A replication factor tuner can use historical data about previous runs of compute jobs to predict execution time periods for jobs scheduled to run in a distributed system, which implements a software framework that utilizes data locality for parallelization of jobs or tasks of the jobs. The replication factor tuner also determines input data sets that are common across the jobs scheduled to run in the distributed system. Based on the predicted execution time periods on commonality of input data sets, the replication factor tuner determines predicted concurrent access of the input data sets by the scheduled compute jobs. The tuner can change replication factors of input data sets that are predicted to be concurrently accessed by a threshold number of the scheduled compute jobs.